1. Home
  2. NMTC vs MLCI Comparison

NMTC vs MLCI Comparison

Compare NMTC & MLCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$0.95

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Logo Mount Logan Capital Inc.

MLCI

Mount Logan Capital Inc.

N/A

Current Price

$3.31

Market Cap

33.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NMTC
MLCI
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
29.2M
33.7M
IPO Year
2010
2026

Fundamental Metrics

Financial Performance
Metric
NMTC
MLCI
Price
$0.95
$3.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$7.27
★ $8.44
AVG Volume (30 Days)
★ 136.7K
12.3K
Earning Date
08-13-2026
11-05-2026
Dividend Yield
N/A
★ 3.65%
EPS Growth
★ 80.43
N/A
EPS
★ N/A
N/A
Revenue
$9,097,692.00
★ $53,566,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$26.57
$36.13
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 163.47
7.58
52 Week Low
$0.61
$2.56
52 Week High
$12.24
$8.68

Technical Indicators

Market Signals
Indicator
NMTC
MLCI
Relative Strength Index (RSI) 29.14 50.67
Support Level $0.61 $3.15
Resistance Level $1.35 $3.30
Average True Range (ATR) 0.09 0.11
MACD 0.01 0.00
Stochastic Oscillator 0.60 52.52

Price Performance

Historical Comparison
NMTC
MLCI

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

About MLCI Mount Logan Capital Inc.

Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.

Share on Social Networks: